SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-054795
Filing Date
2018-10-22
Accepted
2018-10-22 17:27:37
Documents
1
Period of Report
2018-10-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tv505225_8k.htm 8-K 17653
  Complete submission text file 0001144204-18-054795.txt   18735
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 181132892
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1